ARCHIVES

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Illinois Legislature Votes Nearly $1 Million To ICC; Carolyne Davis Resigns From HCFA Jobs

August 2, 1985

House Appropriator Claims NCI, NLM Grants Funded Political Activity, Seeks OIG Probe

March 22, 2013

Appropriations 2014: Obama Plan Good News for NIH, Bad News For Some Oncologists

April 12, 2013

High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer

November 27, 2009

DCPC Board Okays Core Grant Changes On Shared Resources

January 30, 1987

ADT Does Not Raise Risk of Heart Attacks In Men With No History Of Heart Disease

November 25, 2011